Literature DB >> 10433934

Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth.

C D Cool1, J S Stewart, P Werahera, G J Miller, R L Williams, N F Voelkel, R M Tuder.   

Abstract

The plexiform lesions of severe pulmonary hypertension (PH) are complex vascular structures composed primarily of endothelial cells. In this study, we use immunohistochemical markers to identify the various cell layers of pulmonary vessels and to identify different endothelial cell phenotypes in pulmonary arteries affected by severe PH. Our computerized three-dimensional reconstructions of nine vessels in five patients with severe PH demonstrate that plexiform (n = 14) and concentric-obliterative (n = 6) lesions occur distal to branch points of small pulmonary arteries. And, whereas plexiform lesions occur as solitary lesions, concentric-obliterative lesions appear to be only associated with, and proximal to, plexiform structures. The endothelial cells of plexiform lesions express intensely and uniformly the vascular endothelial growth factor (VEGF) receptor KDR and segregate phenotypically into cyclin-kinase inhibitor p27/kip1-negative cells in the central core of the plexiform lesion and p27/kip1-positive cells in peripheral areas adjacent to incipient blood vessel formation. Using immunohistochemistry and three-dimensional reconstruction techniques, we show that plexiform lesions are dynamic vascular structures characterized by at least two endothelial cell phenotypes. Plexiform arteriopathy is not merely an end stage or postthrombotic change--it may represent one stage in an ongoing, angiogenic endothelial cell growth process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10433934      PMCID: PMC1866857          DOI: 10.1016/S0002-9440(10)65137-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Different distribution of plexiform lesions in primary and secondary pulmonary hypertension.

Authors:  B M Jamison; R P Michel
Journal:  Hum Pathol       Date:  1995-09       Impact factor: 3.466

Review 2.  Blood vessel formation: what is its molecular basis?

Authors:  J Folkman; P A D'Amore
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

Review 3.  Pathology of pulmonary hypertension.

Authors:  W D Edwards
Journal:  Cardiovasc Clin       Date:  1988

Review 4.  Differentiation of endothelium.

Authors:  W Risau
Journal:  FASEB J       Date:  1995-07       Impact factor: 5.191

5.  Pulmonary hypertension complicating portal vein thrombosis.

Authors:  J B Saunders; T J Constable; D Heath; P Smith; A Paton
Journal:  Thorax       Date:  1979-04       Impact factor: 9.139

6.  Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; D Saleh
Journal:  N Engl J Med       Date:  1995-07-27       Impact factor: 91.245

7.  Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor.

Authors:  C Patterson; M A Perrella; C M Hsieh; M Yoshizumi; M E Lee; E Haber
Journal:  J Biol Chem       Date:  1995-09-29       Impact factor: 5.157

8.  Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin.

Authors:  J Nourse; E Firpo; W M Flanagan; S Coats; K Polyak; M H Lee; J Massague; G R Crabtree; J M Roberts
Journal:  Nature       Date:  1994-12-08       Impact factor: 49.962

9.  Appetite suppressants and primary pulmonary hypertension in the United Kingdom.

Authors:  S H Thomas; A Y Butt; P A Corris; J J Egan; T W Higenbottam; B P Madden; P C Waller
Journal:  Br Heart J       Date:  1995-12

10.  Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.

Authors:  J Y Kato; M Matsuoka; K Polyak; J Massagué; C J Sherr
Journal:  Cell       Date:  1994-11-04       Impact factor: 41.582

View more
  78 in total

1.  Plexiform lesion in severe pulmonary hypertension: association with glomeruloid lesion.

Authors:  R M Tuder; N F Voelkel
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 2.  5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension.

Authors:  M R MacLean; P Herve; S Eddahibi; S Adnot
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

3.  Idiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstriction.

Authors:  Robert F Wideman; Krishna R Hamal
Journal:  J Pharmacol Toxicol Methods       Date:  2011-01-26       Impact factor: 1.950

Review 4.  Pathobiology of pulmonary arterial hypertension and right ventricular failure.

Authors:  Norbert F Voelkel; Jose Gomez-Arroyo; Antonio Abbate; Harm J Bogaard; Mark R Nicolls
Journal:  Eur Respir J       Date:  2012-06-27       Impact factor: 16.671

5.  Pulmonary hypertension in a patient with adult-onset Stills disease.

Authors:  Eisha Mubashir; M Mubashir Ahmed; Samina Hayat; Maureen Heldmann; Seth Mark Berney
Journal:  Clin Rheumatol       Date:  2006-07-27       Impact factor: 2.980

Review 6.  Pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; John C Marecki; Amy Richter; Iwona Fijalkowska; Sonia Flores
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

Review 7.  Reversible or irreversible remodeling in pulmonary arterial hypertension.

Authors:  Seiichiro Sakao; Koichiro Tatsumi; Norbert F Voelkel
Journal:  Am J Respir Cell Mol Biol       Date:  2009-12-11       Impact factor: 6.914

Review 8.  The pathogenesis of systemic sclerosis revisited.

Authors:  Matthias Geyer; Ulf Müller-Ladner
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

Review 9.  Lung vascular cell heterogeneity: endothelium, smooth muscle, and fibroblasts.

Authors:  Troy Stevens; Sem Phan; Maria G Frid; Diego Alvarez; Erica Herzog; Kurt R Stenmark
Journal:  Proc Am Thorac Soc       Date:  2008-09-15

10.  Room With a View.

Authors:  Lai-Ming Yung; Paul B Yu
Journal:  Circ Cardiovasc Imaging       Date:  2018-08       Impact factor: 7.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.